These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 11422540)

  • 21. Daily intermittent decreases in serum levels of parathyroid hormone have an anabolic-like action on the bones of uremic rats with low-turnover bone and osteomalacia.
    Ishii H; Wada M; Furuya Y; Nagano N; Nemeth EF; Fox J
    Bone; 2000 Feb; 26(2):175-82. PubMed ID: 10678413
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Experimental reproduction of itai-itai disease, a chronic cadmium poisoning of humans, in rats and monkeys.
    Umemura T
    Jpn J Vet Res; 2000 May; 48(1):15-28. PubMed ID: 10927882
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Osteoprotective Effect of Echinocystic Acid, a Triterpone Component from Eclipta prostrata, in Ovariectomy-Induced Osteoporotic Rats.
    Deng YT; Kang WB; Zhao JN; Liu G; Zhao MG
    PLoS One; 2015; 10(8):e0136572. PubMed ID: 26317835
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Action of green tea catechin on bone metabolic disorder in chronic cadmium-poisoned rats.
    Choi JH; Rhee IK; Park KY; Park KY; Kim JK; Rhee SJ
    Life Sci; 2003 Aug; 73(12):1479-89. PubMed ID: 12865088
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparative therapeutic effects of alendronate and alfacalcidol on cancellous and cortical bone mass and mechanical properties in ovariectomized osteopenic rats.
    Iwamoto J; Seki A; Takeda T; Sato Y; Yamada H; Yeh JK
    J Nutr Sci Vitaminol (Tokyo); 2006 Feb; 52(1):1-8. PubMed ID: 16637224
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intermittent minodronic acid treatment with sufficient bone resorption inhibition prevents reduction in bone mass and strength in ovariectomized rats with established osteopenia comparable with daily treatment.
    Kimoto A; Tanaka M; Nozaki K; Mori M; Fukushima S; Mori H; Shiroya T; Nakamura T
    Bone; 2013 Jul; 55(1):189-97. PubMed ID: 23486179
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Daily treatment of aged ovariectomized rats with human parathyroid hormone (1-84) for 12 months reverses bone loss and enhances trabecular and cortical bone strength.
    Fox J; Miller MA; Newman MK; Metcalfe AF; Turner CH; Recker RR; Smith SY
    Calcif Tissue Int; 2006 Oct; 79(4):262-72. PubMed ID: 16969596
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The androgenic anabolic steroid nandrolone decanoate prevents osteopenia and inhibits bone turnover in ovariectomized cynomolgus monkeys.
    Jerome CP; Power RA; Obasanjo IO; Register TC; Guidry M; Carlson CS; Weaver DS
    Bone; 1997 Apr; 20(4):355-64. PubMed ID: 9108356
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A new vitamin D analog, 2MD, restores trabecular and cortical bone mass and strength in ovariectomized rats with established osteopenia.
    Ke HZ; Qi H; Crawford DT; Simmons HA; Xu G; Li M; Plum L; Clagett-Dame M; DeLuca HF; Thompson DD; Brown TA
    J Bone Miner Res; 2005 Oct; 20(10):1742-55. PubMed ID: 16160732
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Combined effect of soy isoflavones and vitamin D3 on bone loss in ovariectomized rats.
    Chang KL; Hu YC; Hsieh BS; Cheng HL; Hsu HW; Huang LW; Su SJ
    Nutrition; 2013 Jan; 29(1):250-7. PubMed ID: 22858193
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of treatment for 6 months with human parathyroid hormone (1-34) peptide in ovariectomized cynomolgus monkeys (Macaca fascicularis).
    Jerome CP; Johnson CS; Vafai HT; Kaplan KC; Bailey J; Capwell B; Fraser F; Hansen L; Ramsay H; Shadoan M; Lees CJ; Thomsen JS; Mosekilde L
    Bone; 1999 Sep; 25(3):301-9. PubMed ID: 10495134
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serum osteocalcin is increased in patients with osteomalacia: correlations with biochemical and histomorphometric findings.
    Demiaux B; Arlot ME; Chapuy MC; Meunier PJ; Delmas PD
    J Clin Endocrinol Metab; 1992 May; 74(5):1146-51. PubMed ID: 1569162
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Regulation of mineral-to-matrix ratio of lumbar trabecular bone in ovariectomized rats treated with risedronate in combination with or without vitamin K2.
    Otomo H; Sakai A; Ikeda S; Tanaka S; Ito M; Phipps RJ; Nakamura T
    J Bone Miner Metab; 2004; 22(5):404-14. PubMed ID: 15316861
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of oviductus ranae and oviductus ranae eggs on bone metabolism and osteoporosis.
    Wang DH; Wu W; Tian JM; Wang ZH; Wang DT; Xiang K; Zhu GY; Han T
    Chin J Integr Med; 2013 Jul; 19(7):532-8. PubMed ID: 23263999
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differences in bone turnover and skeletal response to thyroid hormone treatment between estrogen-depleted and repleted rats.
    Zeni S; Gomez-Acotto C; Di Gregorio S; Mautalen C
    Calcif Tissue Int; 2000 Aug; 67(2):173-7. PubMed ID: 10920223
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Modulatory effects of Aroclors 1221 and 1254 on bone turnover and vertebral histology in intact and ovariectomized rats.
    Yilmaz B; Seyran AD; Sandal S; Aydin M; Colakoglu N; Kocer M; Carpenter DO
    Toxicol Lett; 2006 Oct; 166(3):276-84. PubMed ID: 16978806
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long-term zoledronic acid treatment increases bone structure and mechanical strength of long bones of ovariectomized adult rats.
    Hornby SB; Evans GP; Hornby SL; Pataki A; Glatt M; Green JR
    Calcif Tissue Int; 2003 Apr; 72(4):519-27. PubMed ID: 12574877
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long-term effects of intravenous 1 alpha (OH)D3 combined with CaCO3 and low-calcium dialysis on secondary hyperparathyroidism and biochemical bone markers in patients on chronic hemodialysis.
    Brandi L; Daugaard H; Nielsen PK; Jensen LT; Egsmose C; Olgaard K
    Nephron; 1996; 74(1):89-103. PubMed ID: 8883025
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dolomite supplementation improves bone metabolism through modulation of calcium-regulating hormone secretion in ovariectomized rats.
    Mizoguchi T; Nagasawa S; Takahashi N; Yagasaki H; Ito M
    J Bone Miner Metab; 2005; 23(2):140-6. PubMed ID: 15750692
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.